Jonathan Wygant Veracyte, Inc. (VCYT) insider trading activity

Jonathan Wygant is VP, Chief Accounting Officer of VERACYTE, INC.. Currently has a direct ownership of 37,420 shares of VCYT, which is worth approximately $1.47 Million. The most recent transaction as insider was on Dec 02, 2025, when has been sold 1,325 shares (Common Stock) at a price of $46.16 per share, resulting in proceeds of $61,161. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.4K

20.01% 3M change

7.08% 12M change

Total Value Held $1.47 Million

Jonathan Wygant Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2025	SELL Payment of exercise price or tax liability	$61,161 $46.16 p/Share	1,325 Reduced 3.42%	37,420 Common Stock
Nov 10 2025	SELL Open market or private sale	$215,967 $42.33 p/Share	5,102 Reduced 11.64%	38,745 Common Stock
Nov 07 2025	SELL Open market or private sale	$233,941 $40.21 p/Share	5,818 Reduced 11.71%	43,847 Common Stock
Oct 28 2025	BUY Grant, award, or other acquisition	-	2,886 Added 5.49%	49,665 Common Stock
Sep 02 2025	SELL Payment of exercise price or tax liability	$49,621 $30.11 p/Share	1,648 Reduced 3.4%	46,779 Common Stock
Jun 02 2025	SELL Payment of exercise price or tax liability	$49,415 $26.74 p/Share	1,848 Reduced 3.71%	47,915 Common Stock
Mar 06 2025	BUY Grant, award, or other acquisition	-	13,288 Added 21.08%	49,763 Common Stock

Mar 02 2025	SELL Payment of exercise price or tax liability	$149,502 $34.76 p/Share	4,301 Reduced 10.55%	36,475 Common Stock
Dec 03 2024	SELL Open market or private sale	$41,452 $43.36 p/Share	956 Reduced 2.32%	40,270 Common Stock
Dec 02 2024	SELL Payment of exercise price or tax liability	$47,958 $44.12 p/Share	1,087 Reduced 2.57%	41,226 Common Stock
Nov 27 2024	SELL Open market or private sale	$215,822 $42.89 p/Share	5,032 Reduced 10.63%	42,313 Common Stock
Sep 02 2024	SELL Payment of exercise price or tax liability	$34,294 $31.55 p/Share	1,087 Reduced 2.24%	47,345 Common Stock
Jun 02 2024	SELL Payment of exercise price or tax liability	$22,555 $20.75 p/Share	1,087 Reduced 2.22%	47,971 Common Stock
Mar 06 2024	BUY Grant, award, or other acquisition	-	23,942 Added 32.8%	49,058 Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$56,088 $24.0 p/Share	2,337 Reduced 8.51%	25,116 Common Stock
Dec 02 2023	SELL Payment of exercise price or tax liability	$13,455 $26.54 p/Share	507 Reduced 1.84%	27,020 Common Stock
Sep 02 2023	SELL Payment of exercise price or tax liability	$33,294 $26.7 p/Share	1,247 Reduced 4.33%	27,527 Common Stock
Jun 02 2023	SELL Payment of exercise price or tax liability	$6,947 $26.72 p/Share	260 Reduced 0.91%	28,354 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	8,868 Added 23.66%	28,614 Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$29,498 $24.1 p/Share	1,224 Reduced 5.84%	19,746 Common Stock
Aug 05 2022	BUY Grant, award, or other acquisition	-	8,561 Added 29.4%	20,561 Common Stock

Jonathan Wygant

VP, Chief Accounting Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VCYT shares.

Notify only if

Value

Insider Trading

Get notified when an Veracyte, Inc. insider buys or sells VCYT shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERACYTE, INC.

Track Activities on VCYT

Account